Biomarkers as drug development tools: discovery, validation, qualification and use
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers as drug development tools: discovery, validation, qualification and use
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 14, Issue 6, Pages 354-362
Publisher
Springer Nature
Online
2018-05-14
DOI
10.1038/s41584-018-0005-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New “21st Century Cures” Legislation
- (2017) Aaron S. Kesselheim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biomarkers in connective tissue diseases
- (2017) Neelakshi R. Jog et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
- (2017) Johnny C. Akers et al. Oncotarget
- Age-Related Changes in Plasma Extracellular Vesicle Characteristics and Internalization by Leukocytes
- (2017) Erez Eitan et al. Scientific Reports
- Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium
- (2016) Virginia Byers Kraus et al. ANNALS OF THE RHEUMATIC DISEASES
- The Importance of Biopsy in the Era of Molecular Medicine
- (2016) Etay Ziv et al. CANCER JOURNAL
- FDA's Expedited Approval Mechanisms for New Drug Products
- (2015) Erin E. Kepplinger BIOTECHNOLOGY LAW REPORT
- Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization
- (2015) S Amur et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis
- (2015) V.B. Kraus et al. OSTEOARTHRITIS AND CARTILAGE
- Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use
- (2015) V.B. Kraus et al. OSTEOARTHRITIS AND CARTILAGE
- Osteoarthritis Year in Review 2014: we need more biochemical biomarkers in qualification phase
- (2014) Francisco J. Blanco OSTEOARTHRITIS AND CARTILAGE
- The value of translational biomarkers to phenotypic assays
- (2014) David C. Swinney Frontiers in Pharmacology
- Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-Epitope Approach in the Development of New Biomarkers
- (2013) Sanne Skovgård Veidal et al. DISEASE MARKERS
- Stability study of 81 analytes in human whole blood, in serum and in plasma
- (2012) Christiane Oddoze et al. CLINICAL BIOCHEMISTRY
- Celecoxib pathways
- (2012) Li Gong et al. Pharmacogenetics and Genomics
- Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma
- (2011) Michael E. Wechsler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
- (2011) V.B. Kraus et al. OSTEOARTHRITIS AND CARTILAGE
- A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials
- (2010) David J. Hunter et al. CURRENT DRUG TARGETS
- Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria
- (2010) W.E. van Spil et al. OSTEOARTHRITIS AND CARTILAGE
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Strategic paths for biomarker qualification
- (2008) Federico M. Goodsaid et al. TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search